|
1
|
Awasthi N, Guo S and Wagner BJ: Posterior
capsular opacification: A problem reduced but not yet eradicated.
Arch Ophthalmol. 127:555–562. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Apple DJ, Escobar-Gomez M, Zaugg B,
Kleinmann G and Borkenstein AF: Modern cataract surgery: Unfinished
business and unanswered questions. Surv Ophthalmol. 56(6 Suppl):
S3–S53. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang Y, Ye Y, Lin X, Wu K and Yu M:
Inhibition of pirfenidone on TGF-beta2 induced proliferation,
migration and epithlial-mesen-chymal transition of human lens
epithelial cells line SRA01/04. PLoS One. 8:e568372013. View Article : Google Scholar
|
|
4
|
de Iongh RU, Wederell E, Lovicu FJ and
McAvoy JW: Transforming growth factor-beta-induced
epithelial-mesenchymal transition in the lens: A model for cataract
formation. Cells Tissues Organs. 179:43–55. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saika S, Yamanaka O, Flanders KC, Okada Y,
Miyamoto T, Sumioka T, Shirai K, Kitano A, Miyazaki K, Tanaka S and
Ikeda K: Epithelial-mesenchymal transition as a therapeutic target
for prevention of ocular tissue fibrosis. Endocr Metab Immune
Disord Drug Targets. 8:69–76. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Garweg JG, Zandi S, Gerhardt C and Pfister
IB: Isoforms of TGF-β in the aqueous humor of patients with
pseudoexfoliation syndrome and a possible association with the
long-term stability of the capsular bag after cataract surgery.
Graefes Arch Clin Exp Ophthalmol. 255:1763–1769. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu B, Gao J, Lyu BC, Du SS, Pei C, Zhu ZQ
and Ma B: Expressions of TGF-β2, bFGF and ICAM-1 in lens epithelial
cells of complicated cataract with silicone oil tamponade. Int J
Ophthalmol. 10:1034–1039. 2017.
|
|
9
|
Pei C, Ma B, Kang QY, Qin L and Cui LJ:
Effects of transforming growth factor β2 and connective tissue
growth factor on induction of epithelial mesenchymal transition and
extracellular matrix synthesis in human lens epithelial cells. Int
J Ophthalmol. 6:752–757. 2013.
|
|
10
|
Ma B, Kang Q, Qin L, Cui L and Pei C:
TGF-β2 induces transdifferentiation and fibrosis in human lens
epithelial cells via regulating gremlin and CTGF. Biochem Biophys
Res Commun. 447:689–695. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamada N, Sugai T, Eizuka M, Tsuchida K,
Sugimoto R, Mue Y, Suzuki M, Osakabe M, Uesugi N, Ishida K, et al:
Tumor budding at the invasive front of colorectal cancer may not be
associated with the epithelial-mesenchymal transition. Hum Pathol.
60:151–159. 2017. View Article : Google Scholar
|
|
12
|
Matsuno Y, Coelho AL, Jarai G, Westwick J
and Hogaboam CM: Notch signaling mediates TGF-β1-induced
epithelial-mesenchymal transition through the induction of Snai1.
Int J Biochem Cell Biol. 44:776–789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nieto MA: The snail superfamily of
zinc-finger transcription factors. Nat Rev Mol Cell Biol.
3:155–166. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin Y, Dong C and Zhou BP: Epigenetic
regulation of EMT: The Snail story. Curr Pharm Des. 20:1698–1705.
2014. View Article : Google Scholar :
|
|
15
|
Imai S, Armstrong CM, Kaeberlein M and
Guarente L: Transcriptional silencing and longevity protein Sir2 is
an NAD-dependent histone deacetylase. Nature. 403:795–800. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Wang Y, Shi J, Chai K, Ying X and Zhou BP:
The Role of Snail in EMT and Tumorigenesis. Curr Cancer Drug
Targets. 13:963–972. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dewey S: Posterior capsule opacification.
Curr Opin Ophthalmol. 17:45–53. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang YN, Qin L, Li JM, Chen L and Pei C:
Expression of transcription factors Slug in the lens epithelial
cells undergoing epithelial-mesenchymal transition induced by
connective tissue growth factor. Int J Ophthalmol. 8:872–876.
2015.PubMed/NCBI
|
|
20
|
Liu J, Xu D, Li J, Gao N, Liao C, Jing R,
Wu B, Ma B, Shao Y and Pei C: The role of focal adhesion kinase in
transforming growth factor-β2 induced migration of human lens
epithelial cells. Int J Mol Med. 42:3591–3601. 2018.PubMed/NCBI
|
|
21
|
Li J, Tripathi BJ and Tripathi RC:
Modulation of pre-mRNA splicing and protein production of
fibronectin by TGF-beta2 in porcine trabecular cells. Invest
Ophthalmol Vis Sci. 41:3437–3443. 2000.PubMed/NCBI
|
|
22
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tamiya S, Liu L and Kaplan HJ:
Epithelial-mesenchymal transition and proliferation of retinal
pigment epithelial cells initiated upon loss of cell-cell contact.
Invest Ophthalmol Vis Sci. 51:2755–2763. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dwivedi DJ, Pino G, Banh A, Nathu Z,
Howchin D, Margetts P, Sivak JG and West-Mays JA: Matrix
metalloproteinase inhibitors suppress transforming growth
factor-beta-induced subcapsular cataract formation. Am J Pathol.
168:69–79. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hales AM, Chamberlain CG, Dreher B and
McAvoy JW: Intravitreal injection of TGFbeta induces cataract in
rats. Invest Ophthalmol Vis Sci. 40:3231–3236. 1999.PubMed/NCBI
|
|
26
|
Maring JA, van Meeteren LA, Goumans MJ and
Ten Dijke P: Interrogating TGF-β function and regulation in
endothelial cells. Methods Mol Biol. 1344:193–203. 2016. View Article : Google Scholar
|
|
27
|
Conway J, Al-Zahrani KN, Pryce BR,
Abou-Hamad J and Sabourin LA: Transforming growth factor β-induced
epithelial to mesenchymal transition requires the Ste20-like kinase
SLK independently of its catalytic activity. Oncotarget.
8:98745–98756. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matheus LHG, Simao GM, Amaral TA, Brito
RBO, Malta CS, Matos YST, Santana AC, Rodrigues GGC, Albejante MC,
Bach EE, et al: Indoleamine 2,3-dioxygenase (IDO) increases during
renal fibrogenesis and its inhibition potentiates TGF-β 1-induced
epithelial to mesenchymal transition. BMC Nephrol. 18:2872017.
View Article : Google Scholar
|
|
29
|
Yang L, Xing S, Wang K, Yi H and Du B:
Paeonol attenuates aging MRC-5 cells and inhibits
epithelial-mesenchymal transition of premalignant HaCaT cells
induced by aging MRC-5 cell-conditioned medium. Mol Cell Biochem.
439:117–129. 2018. View Article : Google Scholar
|
|
30
|
Guo R, Meng Q, Guo H, Xiao L, Yang X, Cui
Y and Huang Y: TGF-β2 induces epithelial-mesenchymal transition in
cultured human lens epithelial cells through activation of the
PI3K/Akt/mTOR signaling pathway. Mol Med Rep. 13:1105–1110. 2016.
View Article : Google Scholar
|
|
31
|
Vinnakota JM and Gummadi SN: Snail
represses the expression of human phospholipid scramblase 4 gene.
Gene. 591:433–441. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Medici D, Potenta S and Kalluri R:
Transforming growth factor-β2 promotes Snail-mediated
endothelial-mesenchymal transition through convergence of
Smad-dependent and Smad-independent signalling. Biochem J.
437:515–520. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Takahashi M, Akamatsu H, Yagami A,
Hasegawa S, Ohgo S, Abe M, Iwata Y, Arima M, Mizutani H, Nakata S
and Matsunaga K: Epithelial-mesenchymal transition of the eccrine
glands is involved in skin fibrosis in morphea. J Dermatol.
40:720–725. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu W, Ruest LB and Svoboda KK: Regulation
of epithelial-mesenchymal transition in palatal fusion. Exp Biol
Med (Maywood). 234:483–491. 2009. View Article : Google Scholar
|
|
35
|
Biswas H and Longmore GD: Action of SNAIL1
in cardiac myofibroblasts is important for cardiac fibrosis
following hypoxic injury. PLoS One. 11:e01626362016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang L, Li Z, He W, Xu L, Wang J, Shi J
and Sheng M: Effects of astragaloside IV against the TGF-β1-induced
epithelial-to-mesenchymal transition in peritoneal mesothelial
cells by promoting Smad 7 expression. Cell Physiol Biochem.
37:43–54. 2015. View Article : Google Scholar
|
|
37
|
Batlle E, Sancho E, Franci C, Domínguez D,
Monfar M, Baulida J and García De Herreros A: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
de Ruijter AJ, van Gennip AH, Caron HN,
Kemp S and van Kuilenburg AB: Histone deacetylases (HDACs):
Characterization of the classical HDAC family. Biochem J.
370:737–749. 2003. View Article : Google Scholar
|
|
39
|
Zupkovitz G, Tischler J, Posch M, Sadzak
I, Ramsauer K, Egger G, Grausenburger R, Schweifer N, Chiocca S,
Decker T and Seiser C: Negative and positive regulation of gene
expression by mouse histone deacetylase 1. Mol Cell Biol.
26:7913–7928. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ferrari-Amorotti G, Chiodoni C, Shen F,
Cattelani S, Soliera AR, Manzotti G, Grisendi G, Dominici M, Rivasi
F, Colombo MP, et al: Suppression of invasion and metastasis of
triple-negative breast cancer lines by pharmacological or genetic
inhibition of slug activity. Neoplasia. 16:1047–1058. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
von Burstin J, Eser S, Paul MC, Seidler B,
Brandl M, Messer M, von Werder A, Schmidt A, Mages J, Pagel P, et
al: E-cadherin regulates metastasis of pancreatic cancer in vivo
and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex.
Gastroenterology. 137:361–371. 371.e1–e5. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu YW, Sun M, Xia R, Zhang EB, Liu XH,
Zhang ZH, Xu TP, De W, Liu BR and Wang ZX: LincHOTAIR
epigenetically silences miR34a by binding to PRC2 to promote the
epithelial-to-mesenchymal transition in human gastric cancer. Cell
Death Dis. 6:e18022015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu S, Ye D, Guo W, Yu W, He Y, Hu J, Wang
Y, Zhang L, Liao Y, Song H, et al: G9a is essential for
EMT-mediated metastasis and maintenance of cancer stem cell-like
characters in head and neck squamous cell carcinoma. Oncotarget.
6:6887–6901. 2015.PubMed/NCBI
|
|
44
|
Ziemka-Nalecz M, Jaworska J, Sypecka J and
Zalewska T: Histone deacetylase inhibitors: A therapeutic key in
neurological disorders? J Neuropathol Exp Neurol. 77:855–870. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hahnen E, Hauke J, Trankle C, Eyupoglu IY,
Wirth B and Blumcke I: Histone deacetylase inhibitors: Possible
implications for neurodegenerative disorders. Expert Opin Investig
Drugs. 17:169–184. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mwakwari SC, Patil V, Guerrant W and
Oyelere AK: Macrocyclic histone deacetylase inhibitors. Curr Top
Med Chem. 10:1423–1440. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Duvic M, Talpur R, Ni X, Zhang C, Hazarika
P, Kelly C, Chiao JH, Reilly JF, Ricker JL, Richon VM and Frankel
SR: Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic
acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood.
109:31–39. 2007. View Article : Google Scholar
|
|
48
|
Piekarz RL, Frye R, Turner M, Wright JJ,
Allen SL, Kirschbaum MH, Zain J, Prince HM, Leonard JP, Geskin LJ,
et al: Phase II multi-institutional trial of the histone
deacetylase inhibitor romidepsin as monotherapy for patients with
cutaneous T-cell lymphoma. J Clin Oncol. 27:5410–5417. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Patil V, Sodji QH, Kornacki JR, Mrksich M
and Oyelere AK: 3-Hydroxypyridin-2-thione as novel zinc binding
group for selective histone deacetylase inhibition. J Med Chem.
56:3492–3506. 2013. View Article : Google Scholar : PubMed/NCBI
|
